NASDAQ:PDEX

Pro-Dex (PDEX) Stock Price, News & Analysis

$18.50
-0.25 (-1.33%)
(As of 02:46 PM ET)
Today's Range
$17.65
$18.76
50-Day Range
$16.50
$19.00
52-Week Range
$14.51
$22.99
Volume
4,497 shs
Average Volume
7,942 shs
Market Capitalization
$64.94 million
P/E Ratio
24.67
Dividend Yield
N/A
Price Target
N/A
PDEX stock logo

About Pro-Dex Stock (NASDAQ:PDEX)

Pro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company's products are used in hospitals, medical engineering labs, scientific research facilities, and high-tech manufacturing operations. Pro-Dex, Inc. was founded in 1978 and is headquartered in Irvine, California.

PDEX Stock Price History

PDEX Stock News Headlines

Pro-Dex Inc. (co)
This Apple-like Innovator is Revolutionizing Healthcare
AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.
Monogram Orthopaedics reports FY results
This Apple-like Innovator is Revolutionizing Healthcare
AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.
Pro-Dex Inc PDEX
Pro-Dex, Inc. Announces Fiscal 2024 First Quarter Results
North American Morning Briefing: S&P 500 Futures -2-
Pro-Dex's (NASDAQ:PDEX) Returns Have Hit A Wall
PDEX Pro-Dex, Inc.
See More Headlines
Receive PDEX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pro-Dex and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/08/2024
Today
4/24/2024
Next Earnings (Estimated)
5/02/2024
Fiscal Year End
6/30/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:PDEX
Employees
145
Year Founded
N/A

Profitability

Net Income
$7.07 million
Pretax Margin
8.28%

Debt

Sales & Book Value

Annual Sales
$46.09 million
Cash Flow
$2.26 per share
Book Value
$8.91 per share

Miscellaneous

Free Float
2,015,000
Market Cap
$65.81 million
Optionable
Not Optionable
Beta
0.60
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

PDEX Stock Analysis - Frequently Asked Questions

How have PDEX shares performed in 2024?

Pro-Dex's stock was trading at $17.52 at the beginning of the year. Since then, PDEX stock has increased by 5.6% and is now trading at $18.50.
View the best growth stocks for 2024 here
.

Are investors shorting Pro-Dex?

Pro-Dex saw a decline in short interest during the month of March. As of March 31st, there was short interest totaling 14,800 shares, a decline of 20.4% from the March 15th total of 18,600 shares. Based on an average daily trading volume, of 8,500 shares, the days-to-cover ratio is presently 1.7 days. Approximately 0.6% of the company's shares are short sold.
View Pro-Dex's Short Interest
.

When is Pro-Dex's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 2nd 2024.
View our PDEX earnings forecast
.

How were Pro-Dex's earnings last quarter?

Pro-Dex, Inc. (NASDAQ:PDEX) announced its earnings results on Thursday, February, 8th. The medical instruments supplier reported $0.14 earnings per share for the quarter. The medical instruments supplier had revenue of $12.59 million for the quarter. Pro-Dex had a net margin of 5.59% and a trailing twelve-month return on equity of 8.97%.

What is Michael J. Berthelot's approval rating as Pro-Dex's CEO?

3 employees have rated Pro-Dex Chief Executive Officer Michael J. Berthelot on Glassdoor.com. Michael J. Berthelot has an approval rating of 85% among the company's employees.

What other stocks do shareholders of Pro-Dex own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Pro-Dex investors own include KEMET (KEM), NVIDIA (NVDA), Enterprise Products Partners (EPD), Micron Technology (MU), AT&T (T), AbbVie (ABBV), Alibaba Group (BABA), Bank of America (BAC), Marvell Technology (MRVL) and UnitedHealth Group (UNH).

How do I buy shares of Pro-Dex?

Shares of PDEX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:PDEX) was last updated on 4/24/2024 by MarketBeat.com Staff

From Our Partners